Page last updated: 2024-10-21

14,15-epoxy-5,8,11-eicosatrienoic acid and Infarction, Middle Cerebral Artery

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Infarction, Middle Cerebral Artery in 1 studies

14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y1
Wan, Y1
Fang, Y1
Yao, E1
Xu, S1
Ning, Q1
Zhang, G1
Wang, W1
Huang, X1
Xie, M1

Other Studies

1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Infarction, Middle Cerebral Artery

ArticleYear
Epoxyeicosanoid Signaling Provides Multi-target Protective Effects on Neurovascular Unit in Rats After Focal Ischemia.
    Journal of molecular neuroscience : MN, 2016, Volume: 58, Issue:2

    Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Apoptosis; Epoxide Hydrolases; Infarction, Middle

2016